Series C - Serenex

Series C - Serenex

Investment Firm

Overview

Serenex is a drug discovery and development company focused on oncology.

Announced Date

Oct 06, 2005

Funding Type

Series C

Highlights

Location

United States, North America

Social

N/A

Investor Lead

Ritchie Capital Management

Ritchie Capital Management

No designation

Participant Investors

6

Investor Name
Participant InvestorSeaflower Ventures
Participant InvestorRitchie Capital Management
Participant InvestorLilly Ventures
Participant InvestorIntersouth Partners
Participant InvestorMediphase Venture Partners

Round Details and Background

Serenex raised $30000000 on 2005-10-06 in Series C

Serenex is a drug discovery and development company focused on oncology.

Company Funding History

5

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jun 01, 2001
Series A - Serenex
1-2.0M
Aug 20, 2002
Series B - Serenex
4-15.0M
Jun 28, 2007
Series D - Serenex
9-26.0M
Oct 06, 2005
Series C - Serenex
6-30.0M

Recent Activity

There is no recent news or activity for this profile.